ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
Home
Press release
Jan 19, 2023 09:07 JST
Source:
Eisai
Eisai Listed as a Global 100 Most Sustainable Corporation for The Seventh Time Highest Ranked Global Pharmaceutical Company
TOKYO, Jan 19, 2023 - (JCN Newswire) - Eisai Co., Ltd. announced that it has been listed in the 2023 Global 100 Most Sustainable Corporations in the World (Global 100), a global ranking by Canada-based media and investment advisory company, Corporate Knights, Inc. This marks Eisai's seventh inclusion on the list. Ranked 53rd, Eisai was the highest ranking company among global pharmaceutical companies (please visit here(New Window) for the Global 100 ranking).
The Global 100 evaluates the sustainability of more than 6,000 of the world's major corporations based on various corporate initiatives in areas such as ESG (environment, society and governance). Since 2005, those companies ranking among the top 100 in the world have been announced each year. The Global 100 is based on up to 25 key performance indicators covering ESG initiatives, with the evaluations carried out based on data publicly disclosed in financial filings, integrated reports, or through other such channels. Eisai was highly evaluated, particularly in indicators for enhancing employee value such as safe work environment, sick leave support system and employee retention rate.
Eisai's corporate concept is to give first thought to patients and the people in the daily living domain, and increase the benefits that health care provides to them as well as meet their diversified healthcare needs worldwide. Based on this human health care (hhc) corporate concept, Eisai is striving to sustainably enhance corporate value by strengthening its ESG initiatives and increasing non-financial value.
Media Inquiries:
Public Relations Department,
Eisai Co., Ltd.
+81-(0)3-3817-5120
Source: Eisai
Sectors: BioTech
Copyright ©2024 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.
Latest Release
TANAKA Precious Metals Announces Executive Appointments
Sep 07, 2024 03:00 JST
Panasonic Energy and Mazda to Begin Preparation for Supply of Automotive Lithium-ion Batteries
Sep 06, 2024 16:34 JST
Toyota's Next-Generation BEV Battery Development and Production Plan Certified by METI
Sep 06, 2024 15:10 JST
Toyota Motor Corporation and BMW Group Strengthen Collaboration Towards the Advancement of a Hydrogen Society
Sep 06, 2024 09:26 JST
DENSO Fukushima Launches Production of Inverters
Sep 05, 2024 17:41 JST
Eisai Accelerates Progress in Oncology Research with New Data at ESMO Congress 2024
Sep 05, 2024 16:59 JST
Launch of IOWN Network Solution for 400Gbps High-Speed Inter-Data Center Connections that Reduces Construction and Operation Costs by 50%, and power consumption by 40%
Sep 05, 2024 11:58 JST
Fujitsu and MoBagel revolutionize business processes through accelerated AI prediction
Sep 05, 2024 10:40 JST
Hitachi Develops a Model of BuilMirai Building IoT Solution for Small and Medium-Sized Buildings to Strengthen Green & Smart Building Business
Sep 04, 2024 12:22 JST
Seven Companies Announce to Conduct Engineering Design Work for Japanese Advanced CCS (Carbon Capture and Storage) Project
Sep 04, 2024 11:46 JST
MHI and Mitsubishi Logisnext to Display "SigmaSynX" Products Enabling Autonomous and Intelligent Warehouse Logistics
Sep 04, 2024 09:48 JST
Cisgenics Brings Next-Generation Irrigation Technology to Australia
Sep 03, 2024 13:29 JST
NEC Launches new system using Biometric Authentication Technology
Sep 03, 2024 10:38 JST
Terrific Texas fight back from TOYOTA GAZOO Racing
Sep 02, 2024 17:09 JST
Eisai Announces Status Relating to Acquisition of Own Shares
Sep 02, 2024 15:12 JST
TANAKA Memorial Foundation to Offer Precious Metals Research Grants of Up to 10 Million Yen (from a Grant Pool of 20 Million Yen)
Sep 02, 2024 11:00 JST
Fujitsu establishes Open All-Photonics Network Lab in Europe to promote global expansion of innovative network infrastructure
Aug 30, 2024 18:15 JST
JCB and Permata Launch the Permata JCB Ultimate Card
Aug 30, 2024 17:00 JST
JCB and BINDO Launch World's First Metal JCB Card
Aug 30, 2024 17:00 JST
Intercity Battery Train Starts Testing in the North of England
Aug 29, 2024 19:20 JST
More Latest Release >>
Related Release
Eisai Accelerates Progress in Oncology Research with New Data at ESMO Congress 2024
9/5/2024 4:59:00 PM JST
Eisai Announces Status Relating to Acquisition of Own Shares
9/2/2024 3:12:00 PM JST
Leqembi (lecanemab) Authorized for Early Alzheimer's Disease in Great Britain
8/22/2024 7:54:00 PM JST
"LEQEMBI" (Lecanemab) Approved for the Treatment of Alzheimer's Disease in the United Arab Emirates
8/14/2024 9:59:00 AM JST
Eisai: Update Regarding the Regulatory Status of LEQEMBI Subcutaneous Formulation
8/6/2024 1:15:00 PM JST
New Clinical Data Demonstrates Three Years of Continuous Treatment with Dual-Acting LEQEMBI (lecanemab-irmb) Continues to Significantly Benefit Early Alzheimer's Disease Patients Presented at AAIC 2024
7/31/2024 1:59:00 PM JST
Update on Regulatory Review of Lecanemab for Early Alzheimer's Disease in the European Union
7/29/2024 5:59:00 PM JST
Eisai and EcoNaviSta Enter into Business Alliance Agreement Aimed at Building a Dementia Ecosystem and Commence Collaboration
7/25/2024 10:30:00 AM JST
Eisai to Present Dual-Acting Lecanemab Three-Year Efficacy and Safety Data and Discuss Long-Term Outcomes of Continued Treatment at the Alzheimer's Association International Conference 2024
7/23/2024 8:23:00 PM JST
"LEQEMBI" (Lecanemab) Approved for the Treatment of Alzheimer's Disease in Israel
7/12/2024 12:56:00 PM JST
More Press release >>